MB-CART19.1 in Patients With R/R ALL

NCT03321123 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Precursor B-Lymphoblastic Lymphoma/Leukaemia Refractory

Interventions

DRUG: MB-CART19.1

Sponsor

Shanghai Children's Medical Center

Collaborators

[object Object]